Larvol Delta - Allogeneic-Natural-Killer-NK-Cell-Therapy-in-Subjects-Hospitalized-for-COVID19

DVX201 - Coeptis

http://clinicaltrials.gov/ct2/show/NCT04900454

Mar 15, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next